Ixekizumab for the treatment of psoriasis: up-to-date-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Ixekizumab for the treatment of psoriasis: up-to-date

Published:2020-03-10 Issue:6 Volume:20 Page:549-557
ISSN:1471-2598
Container-title:Expert Opinion on Biological Therapy
language:en
Short-container-title:Expert Opinion on Biological Therapy

Author:

Craig Sarah¹²,Warren Richard B³

Affiliation:

1. Skin cancer and Ageing group, Cancer Research UK Manchester Institute, University of Manchester, Manchester, UK

2. The department of Dermatology, Leeds Teaching Hospitals NHS Foundation Trust, Leeds, UK

3. The Dermatology Centre, Salford Royal NHS Foundation Trust, Manchester NIHR Biomedical Research Centre, The University of Manchester, Salford, UK

Publisher

Informa UK Limited

Subject

Clinical Biochemistry,Drug Discovery,Pharmacology

Link

https://www.tandfonline.com/doi/pdf/10.1080/14712598.2020.1729736

Reference41 articles.

1. The global state of psoriasis disease epidemiology: a workshop report

2. The IL-17 Family of Cytokines in Psoriasis: IL-17A and Beyond

3. The role of IL-17 in psoriasis

4. The efficacy and safety of infliximab in patients with plaque psoriasis who had an inadequate response to etanercept: Results of a prospective, multicenter, open-label study

Cited by 43 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Novel Approaches and Applications of Nanotechnology in the Delivery of Topical Drugs for Psoriasis via Nanocarriers;Current Nanoscience;2024-08-23

2. Multiple Mucosal Ulcers Induced by Ixekizumab: A Case Report;Annals of Otology, Rhinology & Laryngology;2024-05-14

3. Ixekizumab-induced urticaria is associated with the short duration of remission in psoriasis by activation of mast cells;Journal of the American Academy of Dermatology;2024-05

4. Emerging functions and therapeutic targets of IL‐38 in central nervous system diseases;CNS Neuroscience & Therapeutics;2024-02

5. Immune cells in the epithelial immune microenvironment of psoriasis: emerging therapeutic targets;Frontiers in Immunology;2024-01-04

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3